{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,7]],"date-time":"2025-12-07T04:26:24Z","timestamp":1765081584259,"version":"3.46.0"},"reference-count":27,"publisher":"BMJ","issue":"4","license":[{"start":{"date-parts":[[2023,4,21]],"date-time":"2023-04-21T00:00:00Z","timestamp":1682035200000},"content-version":"unspecified","delay-in-days":20,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["MS3 \u2013 173107"],"award-info":[{"award-number":["MS3 \u2013 173107"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2023,3,29]]},"published-print":{"date-parts":[[2023,4]]},"abstract":"<jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>The aim of this study was to investigate physician benzodiazepine (BZD) self-use pre-COVID-19 pandemic and to examine changes in BZD self-use during the first year of the pandemic.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>Population-based retrospective cohort study using linked routinely collected administrative health data comparing the first year of the pandemic to the period before the pandemic.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Setting<\/jats:title>\n                    <jats:p>Province of Ontario, Canada between March 2016 and March 2021.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Participants<\/jats:title>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Intervention<\/jats:title>\n                    <jats:p>Onset of the COVID-19 pandemic in March 2020.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Outcomes measures<\/jats:title>\n                    <jats:p>The primary outcome measure was the receipt of one or more prescriptions for BZD, which was captured via the Narcotics Monitoring System.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      In a cohort of 30\u2009798 physicians (mean age 42, 47.8% women), we found that during the year before the pandemic, 4.4% of physicians had 1 or more BZD prescriptions. Older physicians (6.8% aged 50+ years), female physicians (5.1%) and physicians with a prior mental health (MH) diagnosis (12.4%) were more likely than younger (3.7% aged &lt;50 years), male physicians (3.8%) and physicians without a prior MH diagnosis (2.9%) to have received 1 or more BZD prescriptions. The first year of the COVID-19 pandemic was associated with a 10.5% decrease (adjusted OR (aOR) 0.85, 95%\u2009CI: 0.80 to 0.91) in the number of physicians with 1 or more BZD prescriptions compared with the year before the pandemic. Female physicians were less likely to reduce BZD self-use (aOR\n                      <jats:sub>female<\/jats:sub>\n                      =0.90, 95%\u2009CI: 0.83 to 0.98) compared with male physicians (aOR\n                      <jats:sub>male<\/jats:sub>\n                      =0.79, 95%\u2009CI: 0.72 to 0.87, p\n                      <jats:sub>interaction<\/jats:sub>\n                      =0.046 during the pandemic. Physicians presenting with an incident MH visit had higher odds of filling a BZD prescription during COVID-19 compared with the prior year.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Physicians\u2019 BZD prescriptions decreased during the first year of the COVID-19 pandemic in Ontario, Canada. These findings suggest that previously reported increases in mental distress and MH visits among physicians during the pandemic did not lead to greater self-use of BZDs.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2022-062742","type":"journal-article","created":{"date-parts":[[2023,4,21]],"date-time":"2023-04-21T11:11:24Z","timestamp":1682075484000},"page":"e062742","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":1,"title":["Physician benzodiazepine self-use prior to and during the COVID-19 pandemic in Ontario, Canada: a population-level cohort study"],"prefix":"10.1136","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8038-300X","authenticated-orcid":false,"given":"Daniel","family":"Myran","sequence":"first","affiliation":[{"name":"Department of Family Medicine, University of Ottawa, Ottawa, Ontario, Canada"},{"name":"Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada"},{"name":"Bruyere Research Institute, Ottawa, Ontario, Canada"},{"name":"ICES, Ottawa, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2561-962X","authenticated-orcid":false,"given":"Christina","family":"Milani","sequence":"additional","affiliation":[{"name":"Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada"},{"name":"Division of Palliative Care, Bruyere Research Institute, Ottawa, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Pugliese","sequence":"additional","affiliation":[{"name":"Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada"},{"name":"ICES, Ottawa, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4194-6049","authenticated-orcid":false,"given":"Jennifer M","family":"Hensel","sequence":"additional","affiliation":[{"name":"University of Manitoba, Winnipeg, Manitoba, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9146-2344","authenticated-orcid":false,"given":"Manish","family":"Sood","sequence":"additional","affiliation":[{"name":"Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada"},{"name":"ICES, Ottawa, Ontario, Canada"},{"name":"Division of Nephrology, Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claire E","family":"Kendall","sequence":"additional","affiliation":[{"name":"Department of Family Medicine, University of Ottawa, Ottawa, Ontario, Canada"},{"name":"Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetyana","family":"Kendzerska","sequence":"additional","affiliation":[{"name":"Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada"},{"name":"ICES, Ottawa, Ontario, Canada"},{"name":"Respirology, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Tanuseputro","sequence":"additional","affiliation":[{"name":"Department of Family Medicine, University of Ottawa, Ottawa, Ontario, Canada"},{"name":"Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada"},{"name":"ICES, Ottawa, Ontario, Canada"},{"name":"Division of Palliative Care, Bruyere Research Institute, Ottawa, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2023,4,21]]},"reference":[{"key":"2025120618541267000_13.4.e062742.1","doi-asserted-by":"crossref","unstructured":"Mata DA , Ramos MA , Bansal N , et al . Prevalence of depression and depressive symptoms among resident physicians a systematic review and meta-analysis. JAMA - J Am Med Assoc 2015. doi:10.1001\/jama.2015.15845","DOI":"10.1001\/jama.2015.15845"},{"key":"2025120618541267000_13.4.e062742.2","doi-asserted-by":"crossref","DOI":"10.1186\/1472-6963-14-254","article-title":"An estimate of the cost of burnout on early retirement and reduction in clinical hours of practicing physicians in Canada","volume":"14","author":"Dewa","year":"2014","journal-title":"BMC Health Serv Res"},{"key":"2025120618541267000_13.4.e062742.3","unstructured":"CMA . CMA national physician health survey: A national snapshot. n.d."},{"key":"2025120618541267000_13.4.e062742.4","doi-asserted-by":"publisher","DOI":"10.1111\/ajad.12173"},{"key":"2025120618541267000_13.4.e062742.5","doi-asserted-by":"publisher","DOI":"10.9778\/cmajo.20200057"},{"key":"2025120618541267000_13.4.e062742.6","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.m1211","article-title":"Managing mental health challenges faced by healthcare workers during covid-19 pandemic","volume":"368","author":"Greenberg","year":"2020","journal-title":"BMJ"},{"key":"2025120618541267000_13.4.e062742.7","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.annemergmed.2020.05.023","article-title":"Moral injury: the invisible epidemic in COVID health care workers","volume":"76","author":"Dean","year":"2020","journal-title":"Ann Emerg Med"},{"key":"2025120618541267000_13.4.e062742.8","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.3976","article-title":"Factors associated with mental health outcomes among health care workers exposed to coronavirus disease 2019","volume":"3","author":"Lai","year":"2020","journal-title":"JAMA Netw Open"},{"key":"2025120618541267000_13.4.e062742.9","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.5694-20"},{"key":"2025120618541267000_13.4.e062742.10","doi-asserted-by":"crossref","DOI":"10.1186\/s12888-021-03637-w","article-title":"The new frontline: exploring the links between moral distress, moral resilience and mental health in healthcare workers during the COVID-19 pandemic","volume":"22","author":"Spilg","year":"2022","journal-title":"BMC Psychiatry"},{"key":"2025120618541267000_13.4.e062742.11","doi-asserted-by":"crossref","DOI":"10.1192\/bjo.2021.988","article-title":"COVID-19 staff wellbeing survey: longitudinal survey of psychological well-being among health and social care staff in Northern Ireland during the COVID-19 pandemic","volume":"7","author":"Jordan","year":"2021","journal-title":"BJPsych Open"},{"key":"2025120618541267000_13.4.e062742.12","unstructured":"Statistics Canada . Mental health among health care workers in canada during the COVID-19 pandemic. n.d."},{"key":"2025120618541267000_13.4.e062742.13","unstructured":"Ontario\u2019s doctors report increased burnout, propose five solutions. n.d."},{"key":"2025120618541267000_13.4.e062742.14","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.43160","article-title":"Physician health care visits for mental health and substance use during the COVID-19 pandemic in Ontario, Canada","volume":"5","author":"Myran","year":"2022","journal-title":"JAMA Netw Open"},{"key":"2025120618541267000_13.4.e062742.15","doi-asserted-by":"publisher","DOI":"10.1093\/eurpub\/ckm020"},{"key":"2025120618541267000_13.4.e062742.16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2006.10.023"},{"key":"2025120618541267000_13.4.e062742.17","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2020-044891","article-title":"Changes in benzodiazepine use in the French general population after November 2015 terrorist attacks in Paris: an interrupted time series analysis of the National CONSTANCES cohort","volume":"11","author":"Gouraud","year":"2021","journal-title":"BMJ Open"},{"key":"2025120618541267000_13.4.e062742.18","doi-asserted-by":"publisher","DOI":"10.1177\/0004867415589794"},{"key":"2025120618541267000_13.4.e062742.19","doi-asserted-by":"publisher","DOI":"10.9778\/cmajo.20140027"},{"key":"2025120618541267000_13.4.e062742.20","doi-asserted-by":"crossref","unstructured":"Sarangi A , McMahon T , Gude J . Benzodiazepine misuse: an epidemic within a pandemic. Cureus 2021;13. doi:10.7759\/cureus.15816","DOI":"10.7759\/cureus.15816"},{"key":"2025120618541267000_13.4.e062742.21","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0237301","article-title":"Exposure to COVID-19 patients increases physician trainee stress and burnout","volume":"15","author":"Kannampallil","year":"2020","journal-title":"PLoS ONE"},{"key":"2025120618541267000_13.4.e062742.22","unstructured":"COVID-19 intervention timeline in canada | CIHI. n.d. Available: https:\/\/www.cihi.ca\/en\/covid-19-intervention-timeline-in-canada"},{"key":"2025120618541267000_13.4.e062742.23","doi-asserted-by":"publisher","DOI":"10.9778\/cmajo.20210263"},{"key":"2025120618541267000_13.4.e062742.24","unstructured":"Statistics Canada . CMA and CA: detailed definition. 2018."},{"key":"2025120618541267000_13.4.e062742.25","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1002\/da.23228","article-title":"The effects of COVID-19 on the dispensing rates of antidepressants and benzodiazepines in Canada","volume":"39","author":"Uthayakumar","year":"2022","journal-title":"Depress Anxiety"},{"key":"2025120618541267000_13.4.e062742.26","unstructured":"Ontario Newsroom . Ontario lifting 30-day supply limit on prescriptions. n.d. Available: https:\/\/news.ontario.ca\/en\/release\/57185\/ontario-lifting-30-day-supply-limit-on-prescriptions"},{"key":"2025120618541267000_13.4.e062742.27","unstructured":"Characterizing prescription benzodiazepine use among community- dwelling residents of ontario, canada april 2021 about the ODPRN ODPRN citizens\u2019 panel. Ontario Drug Policy Res Netw Citizens\u2019 Panel April 2021. doi:10.31027\/ODPRN.2021.01.For"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2022-062742","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,7]],"date-time":"2025-12-07T02:54:20Z","timestamp":1765076060000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2022-062742"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":27,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2023,4,21]]},"published-print":{"date-parts":[[2023,4]]}},"alternative-id":["10.1136\/bmjopen-2022-062742"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2022-062742","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"type":"print","value":"2044-6055"},{"type":"electronic","value":"2044-6055"}],"subject":[],"published":{"date-parts":[[2023,4]]}}}